Archon Biosciences
PrivateLast Round
Seed
Oct 30, 2024
Total Funding Raised
$27M
Company Overview
Archon Biosciences is a biotechnology company that develops computationally designed Antibody Cages (AbCs) to unlock therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
antibody cagesAbCscomputational protein designgenerative protein designprotein engineeringbiologic therapeuticsdrug discoveryAI-driven drug discoveryprotein nanostructuresin silico drug designbiotech platformtherapeutic antibodypreclinical developmentprotein design lab
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Archon Biosciences Comparables
Compare Archon Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accipiter Biosciences | 85% | |
| AI Proteins | 77% | |
| Onava | 76% | |
Archon Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2024 |
Key People
Founding team and executive leadership
Archon Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duke University Management Company | Seed |
| Cornucopian Capital | Seed |
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| WRF Capital | Seed |
| Pack Ventures | Seed |
| Washington Research Foundation Capital | Seed, Grant |
Archon Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Archon Biosciences's valuation, stock price, and market status.
Firmographic Details
HeadquartersSeattle, Washington
Employee Range26
Year Founded2023
Last FundingOct 30, 2024